title: Surgical pathology examination of radical prostatectomy specimens. Updated protocol based on the Italian TAP study.
abstract: Between January 1996 and June 2000, 192 men with prostate cancer underwent radical retropubic prostatectomy (RP) and bilateral pelvic node dissection in 26 centers participating in the Italian randomized prospective TAP study. The reviewing pathologist evaluated 145 RP specimens. Seventy-five cases had not been treated with total androgen ablation before RP was performed, whereas 70 had been treated for three months. Whole-mount sectioning of the complete radical prostatectomy specimens was adopted in each center for accurately evaluating the pathological stage of prostate cancer and resection limit status. The results of this study suggest that total androgen ablation before RP is beneficial in men with clinical stage T2 because of the significant pathological down-staging and decrease in the number of positive margins in the RP specimens. On the basis of the experience acquired through the Italian TAP study and recent publications on prognostic factors in prostate cancer, the original practice protocol for examination of RP specimens removed from patients with carcinoma of the prostate glands was updated.
authors.affiliation: Institute of Pathological Anatomy, University of Ancona School of Medicine, Italy.
authors.forename: R
authors.initials: R
authors.lastname: Mazzucchelli
authors.forename: R
authors.initials: R
authors.lastname: Montironi
authors.forename: D
authors.initials: D
authors.lastname: Prezioso
authors.forename: A V
authors.initials: AV
authors.lastname: Bono
authors.forename: P
authors.initials: P
authors.lastname: Ferrari
authors.forename: A
authors.initials: A
authors.lastname: Manganelli
authors.forename: P
authors.initials: P
authors.lastname: Morelli
authors.forename: M L
authors.initials: ML
authors.lastname: De Vito
authors.forename: A
authors.initials: A
authors.lastname: Santinelli
authors.forename: L
authors.initials: L
authors.lastname: Diamanti
authors.forename: T
authors.initials: T
authors.lastname: Lotti
authors.forename: M
authors.initials: M
authors.lastname: Polito
mesh_terms: D000726:Androgen Antagonists / Q000627:therapeutic use; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D006801:Humans; D008297:Male; D020360:Neoadjuvant Therapy; D009367:Neoplasm Staging; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000188:drug therapy / Q000473:pathology* / Q000601:surgery*
chemical_list: D000726:Androgen Antagonists; D018931:Antineoplastic Agents, Hormonal